phosphoserine has been researched along with Fragile X Syndrome in 1 studies
Phosphoserine: The phosphoric acid ester of serine.
Fragile X Syndrome: A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coffee, RL | 1 |
| Williamson, AJ | 1 |
| Adkins, CM | 1 |
| Gray, MC | 1 |
| Page, TL | 1 |
| Broadie, K | 1 |
1 other study available for phosphoserine and Fragile X Syndrome
| Article | Year |
|---|---|
In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation.
Topics: Animals; Animals, Genetically Modified; Brain; Cytoskeleton; Disease Models, Animal; Drosophila mela | 2012 |